UCB Pharma (United Kingdom)

1.1k papers and 45.0k indexed citations i.

About

In recent decades, authors affiliated with UCB Pharma (United Kingdom) have published 1.1k papers, which have received a total of 45.0k indexed citations. Scholars at this organization have produced 429 papers in Molecular Biology, 314 papers in Immunology and 192 papers in Radiology, Nuclear Medicine and Imaging on the topics of Monoclonal and Polyclonal Antibodies Research (187 papers), Psoriasis: Treatment and Pathogenesis (100 papers) and Spondyloarthritis Studies and Treatments (79 papers). Their work is cited by papers focused on Molecular Biology (19.9k citations), Immunology (9.1k citations) and Oncology (6.5k citations). Authors at UCB Pharma (United Kingdom) collaborate with scholars in United Kingdom, United States and Belgium and have published in prestigious journals including Nature, Science and Cell. Some of UCB Pharma (United Kingdom)'s most productive authors include Jiye Shi, Gillian Murphy, Andrew Docherty, Chunhai Fan, Andrew P. Chapman, Bryan Ronain Smith, Charlotte M. Deane, Stefan Schreiber, Frances Willenbrock and Vera Knäuper.

In The Last Decade

Fields of papers published by authors at UCB Pharma (United Kingdom)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with UCB Pharma (United Kingdom) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with UCB Pharma (United Kingdom) at the time of their publication.

Countries citing scholars working at UCB Pharma (United Kingdom)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at UCB Pharma (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at UCB Pharma (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites UCB Pharma (United Kingdom) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Nagahama Institute of Bio-Science and Technology Breakdown of academic impact, for scholars at Canada–France–Hawaii Telescope Breakdown of academic impact, for scholars at Cluster of Excellence on Plant Sciences Breakdown of academic impact, for scholars at National Institute for Health and Care Excellence Breakdown of academic impact, for scholars at Cancer Prevention Institute of California Breakdown of academic impact, for scholars at Research Council of Finland Breakdown of academic impact, for scholars at Institut de Microbiologie de la Méditerranée Breakdown of academic impact, for scholars at Occupational Cancer Research Centre
Rankless by CCL
2025